Myelodysplastic syndromes. A multiparametric study of prognostic factors in 336 patients
- 15 December 1987
- Vol. 60 (12) , 3029-3032
- https://doi.org/10.1002/1097-0142(19871215)60:12<3029::aid-cncr2820601229>3.0.co;2-4
Abstract
Two groups of patients with a myelodysplastic syndrome (MDS) were analyzed by univariate (log-rank test) and multivariate (logistic regression) analyses to detect the most important prognostic factors. By stepwise analysis, the variables found to have prognostic significance for death were as follows: age, percentage of marrow blasts, presence of circulating blasts, and number of platelets. The variables found significant for predicting progression to acute leukemia (AL) were as follows: hemoglobin level, percentage of marrow blasts, and presence of circulating blasts. The first group of 193 patients was used to build a prognostic index which reflected the probability of a given patient dying or progressing to AL within 6, 9, or 12 months. The application of this prognostic index to a test group of 143 patients was used to determine the expected error rate and the validity of the prediction rule.This publication has 15 references indexed in Scilit:
- Dysmyelopoietic syndromes a search for prognostic factors in 193 patientsCancer, 2006
- Clinical Prediction RulesNew England Journal of Medicine, 1985
- Myelodysplastic syndromes. A clinical and pathologic analysis of 109 casesCancer, 1985
- Myelodysplastic syndromes: a scoring system with prognostic significanceBritish Journal of Haematology, 1985
- Modifications in the classification of primary myelodysplastic syndromes: The addition of a scoring systemHematological Oncology, 1985
- MYELODYSPLASTIC SYNDROMES: IS ANOTHER CLASSIFICATION NECESSARY?British Journal of Haematology, 1984
- Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemiaBritish Journal of Haematology, 1983
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958